Should you buy these healthcare shares?

Should you buy CSL Limited (ASX:CSL) shares and two others in the healthcare sector?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

One of the best performing areas of the share market over the last 12 months has been the healthcare sector.

During this time the S&P/ASX 200 Health Care (Index: ^AXHJ) (ASX: XHJ) has managed to put on a gain of almost 27%.

While I wouldn't necessarily expect the sector to replicate this gain over the next 12 months, thanks to Australia's ageing population and increasing chronic disease burden I still believe it could continue to outperform the rest of the market.

With that in mind, should you buy these three healthcare shares?

CSL Limited (ASX: CSL)

The strong performance of this biotherapeutics company's shares over the last 12 months have played a key role in taking the S&P/ASX 200 Health Care index higher. While this leaves its shares close to an all-time high, I don't think it is too late to invest if you're prepared to hold them for the long-term. However, if you're more focused on the short term you might want to wait in hope of a pullback in its share price before investing.

Nanosonics Ltd (ASX: NAN)

I'm a big fan of this infection control specialist and believe it could have a very bright future ahead of it. Especially given its plan to release complementary products in the near future that will both boost and diversify its revenue. One thing of note, though, is that the company is currently being targeted by short sellers and is one of the most shorted shares on the Australian share market. It is unclear why short sellers have taken an interest, which does leave me concerned that they know something that I don't. Because of this, I'm staying clear of Nanosonics until short interest fades.

Ramsay Health Care Limited (ASX: RHC)

Ramsay Health Care is one of the world's leading private hospital operators. Whilst I am a huge fan of Ramsay and would love to have it in my portfolio, I'm keeping away from the company until its shares are trading at a level more befitting of its current growth profile. At present Ramsay's growth is being held back by weakness in Europe and falling private hospital coverage here in Australia.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face.
Healthcare Shares

Up 60%: Why this exciting ASX stock could keep rising

This speculative stock could still have significant upside according to Bell Potter.

Read more »

A person holds their hands up through the middle of a rubber lifesaving ring while swimming in relatively calm conditions at a beach.
Healthcare Shares

Why this ASX healthcare high-flyer just dropped another 9% today

4DMedical shares are sliding again. Here’s what’s behind the drop.

Read more »

Three scientists wearing white coats and blue gloves dance together in a lab.
Healthcare Shares

Mayne Pharma stock jumps 8% on strong Q3 update. Has it finally bottomed?

Mayne Pharma's share price has rebounded 32% since hitting a five-year low in March.

Read more »

A young woman sits with her hand to her chin staring off to the side thinking about her investments.
Healthcare Shares

Down 65%, are Cochlear shares a once-in-a-decade buying opportunity?

After a brutal drop, sentiment has turned negative. But looking beyond the next year, the long-term story may still be…

Read more »

Two lab workers fist pump each other.
Healthcare Shares

A big milestone for this ASX biotech. Here's why the share price is moving

Mesoblast hits a key trial milestone...

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Healthcare Shares

Mesoblast shares in focus after key Phase 3 milestone for low back pain

Mesoblast shares are in focus after reaching a major patient recruitment milestone in its pivotal Phase 3 trial for chronic…

Read more »

CEO of a company talking.
Healthcare Shares

Regis Healthcare names Andrew Kinkade as new CEO

Regis Healthcare appoints Andrew Kinkade as CEO, unveiling new leadership strategy and key remuneration details.

Read more »

ASX share investor sitting with a laptop on a desk, pondering something.
Share Fallers

CSL shares crash to a 9-year low. Is it time to sell off my shares?

What's next for the beaten-down ASX biotech stock?

Read more »